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Abstract 
The synthesis of 14C labelled arachidonic acid metabolites was measured in colonic tissues obtained from 
mice, rats, guinea pigs, rabbits, piglets and in colonic biopsies from humans during colonoscopy. The main 
eicosanoids formed after stimulation with calcium ionophore A23187 were: in humans, 15-hydroxy- 
eicosatetraenoic acid (15-HETE); in mice, 12-HETE; in rats, 12-HETE, 12-hydroxy- 5,8,10-heptadecatrien- 
oic acid (HHT) and 6-keto-prostaglandine FI~ (6kPGFI~); in guinea pigs, PGD2; in rabbits, 6kPGFI~ ,
PGE 2 and 15-HETE; and in pigs PGE 2 and 12-HETE. In inflamed 15-HETE production was increased in 
man, HHT and 12-HETE production in rats and overall eicosanoid production in mice. 
Introduction 
Several experimental models have been described 
which resemble idiopathic human inflammatory 
bowel disease (ulcerative colitis and Crohn's dis- 
ease), and these animal models have been used to 
study the biochemistry of intestinal mucosal in- 
flammation and the effects of various forms of 
treatment [1]. The usual treatments of idiopathic 
inflammatory bowel disease - corticosteroids and 
5-aminosalicylates - are thought to act by inter- 
fering with eicosanoid production. In recent years 
more specific blockers of arachidonate metabolites 
have become available, and these are of potential 
interest in the treatment of inflammatory bowel 
disease. It would greatly aid the development of 
new treatments if there would be an animal model 
which was very similar to human inflammatory 
bowel disease, not only histologically but also in 
the pattern of eicosanoids produced in the inflamed 
mucosa. 
In the search for a suitable animal model for 
ulcerative colitis (UC), we compared the pattern of 
arachidonate metabolites produced by the colonic 
mucosa of 5 animal species with that of man. In this 
study we examined eicosanoid production patterns 
in normal mucosa and in inflamed mucosa. 
Methods 
Normal colonic mucosa was obtained from 
8 BALB/c mice (female), 6 Wistar rats (male), 
5 NZW rabbits (male), 5 albino guinea pigs (female) 
and 5 Dutch piglets (female) immediately after 
sacrificing the animals, and biopsies were taken 
from humans during colonoscopy. In this study 
13 patients (6 men, 7 women) from whom any kind 
of inflammatory bowel disease was excluded (in 
most patients the colonoscopy was performed as a 
follow up 1-2 years after polypectomy) were con- 
sidered as controls and in addition 11 patients 
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Table 1 
Eicosanoid production by colonic tissue from humans, rats and mice (expressed asdpm per 100 mg tissue). 
IkPGFI~, 
='GF2~ 
~GE 2 
~GD 2 
HT 
.TB 4 
i-HETE 
~-HETE 
2-HETE 
5-HETE 
HUMANS RATS MICE 
contr, inflamm, contr, inflamm, contr, inflamm. 
450 • 80 
670 • 80 
810 • 110 
450 • 90 
1170 • 230 
250 • 40 
440 • 70 
30 
360 • 40 
2470 • 260 
270 • 40 
530 • 60 
610 • 80 
450 • 100 
1200 • 120 
230 • 40 
290 • 40 
3O 
570 • 70 
3690 • 390 
2850 • 510 
250 • 5O 
450 • 190 
510 • 150 
1230 • 300 
610 • 130 
390 • 90 
30 
1610 • 160 
270 • 60 
3450 • 1240 
340 • 110i 
530 • 280 
240 • 90 
2530 • 200 
960 • 180 
430 • 30 
30 
i4610 • 1220 
340 • 60 
340 + 70 
140+ 30 
220 + 30 
230 + 50 
230 + 30 
< 30 
< 30 
< 30 
480 + 110 
130 + 2O 
1820 + 210 
1020 + 160 
1230 + 180 
1330 + 160 
1020 + 130 
320 + 40 
250 + 20 
350 + 50 
1860 + 23O 
980 + 180 
(8 men, 3 women) with a non-treated UC were 
examined as examples of inflammatory bowel 
disease. 
Experimental colitis in rats was induced by injec- 
tion of 2 ml of 5% acetic acid into the lumen of the 
colon. Twenty-four hours later the animals were 
killed and the colons removed [2]. Colitis in mice 
was induced by the addition of dextran sulphate 
sodium to the drinking water, 10% (w/v) ad libitum 
[3]. 
Tissue samples were homogenised in Krebs buffer, 
incubated for 10 min with 0.125 laCi 14C-arachi- 
donic acid (Amersham, UK) and stimulated with 
Ca-ionophore A23187 (1 laM). The radiolabelled 
eicosanoids formed were separated by HPLC and 
measured by on-line beta detection [4]. 
Results 
In the comparison of non-inflamed tissues obtained 
from six different species, including man, the fol- 
lowing was observed. The main eicosanoids formed 
are: in humans, 15-HETE; in mice, 12-HETE; in 
rats, 12-HETE, HHT and 6kPGFI~; in guinea pigs, 
PGD2, diHETE and a number of unidentified 
metabolites; in rabbits, 6kPGFI~, PGE 2 and 15- 
HETE; and in pigs, PGE2 and 12-HETE. LTB 4 in 
humans was present in the lowest amounts and was 
barely detectable in the other 5 species. 
Eicosanoid production by inflamed colonic tissue 
was increased in the three models used (Table 1). 
In man, a 50% increase was observed in 12- and 
15-HETE formation. In rats, mainly HHT and 
12-HETE production was markedly increased. 
In mice, the overall eicosanoid formation was 
increased 5-fold. 
Discussion 
In previous tudies we have shown that there are 
marked species and site differences in the produc- 
tion pattern of eicosanoids by inflammatory cells 
[5]. The present study, in which tissue homoge- 
nares were used, again illustrates the species differ- 
ences in inflammatory mediator production. While 
this probably has little implication for study of the 
effects of less specific anti-inflammatory agents 
such as 5-aminosalicylate, which have a diffuse 
suppressive action on eicosanoid formation, it is 
probably important while designing studies of spe- 
cific receptor blockers or specific enzyme blockers 
as potential drugs for human inflammatory bowel 
disease. 
Conclusions 
There are marked species differences in eicosanoid 
production by inflamed and non-inflamed colonic 
mucosa. These differences hould be taken into 
account while comparing animal models with 
human inflammatory bowel disease. 
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